Treasure Global Signs MOU to Expand Medical Supply and Pharmaceutical Distribution Across Southeast Asia
Key Highlights
- ➤Treasure Global (TGL) signs MOU with Union Concept for regional healthcare distribution
- ➤Six-month exclusivity period covers proposed Malaysia and Southeast Asia collaboration
- ➤MOU is non-binding; definitive commercial terms remain subject to negotiation
- ➤Malaysia pharmaceutical market projected to grow from RM11.2 billion in 2022 to RM15.5 billion by 2027
- ➤Southeast Asia medical device market projected to reach approximately US$15.8 billion by 2028
Expert Statements
Sam Teo, Acting Chief Executive Officer of Treasure Global
“Healthcare and pharmaceutical distribution represent a strategic extension of Treasure Global’s existing commerce capabilities”
Sam Teo, Acting Chief Executive Officer of Treasure Global
“We believe this collaboration provides an opportunity to enter a large and growing sector while leveraging infrastructure and market relationships that Treasure Global has already established.”
Sam Teo, Acting Chief Executive Officer of Treasure Global
“Over time, we see potential to build a scalable healthcare distribution vertical serving government, institutional and commercial demand across the region.”
KUALA LUMPUR, Malaysia, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Treasure Global Inc. (NASDAQ: TGL) (“Treasure Global” or the “Company”), a Southeast Asia–anchored technology company focused on AI-powered enterprise solutions and digital transformation, today announced that it has signed a Memorandum of Understanding (“MOU”) with Union Concept Trading Pte. Ltd. (“Union Concept”), a Singapore-based medical and pharmaceutical supply company, to establish a strategic collaboration in the sourcing, marketing and distribution of medical solutions and pharmaceutical products across Malaysia and selected regional markets.
The partnership brings together Treasure Global’s digital commerce, distribution and regional market-access capabilities with Union Concept’s healthcare sourcing, manufacturing and regulatory expertise. Together, the parties intend to establish an integrated framework to support product commercialization, institutional procurement and regional distribution across the medical and pharmaceutical sectors.
Get started
Create a free account to read the full story.